Day: December 20, 2023

Winnebago Industries Reports First Quarter Fiscal 2024 Results

Written by Customer Service on December 20, 2023. Posted in Earnings Releases And Operating Results.

— Diversified Portfolio of Premium Products Demonstrates Continued Resilience in Challenging Market Environment —— Maintains Healthy Gross Profit Margins of 15.2%, Driven by Strong Execution in Towable RV Business —— Barletta Continues to Gain Market Share in the Aluminum Pontoon Market —— Returned $50 Million to Shareholders Through Share Repurchases and Dividends, While Further Investing in Innovation, Digital Assets and IT Capabilities — EDEN PRAIRIE, Minn., Dec. 20, 2023 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today reported financial results for the Company’s Fiscal 2024 first quarter. First Quarter Fiscal 2024 ResultsRevenues for the Fiscal 2024 first quarter ended November 25, 2023, were $763.0 million,...

Form 8.3 – [Young & Co.’s Brewery plc – 19 12 2023]

Written by Customer Service on December 20, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree YOUNG & CO.’S BREWERY PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Form 8.3 – [LondonMetric Property plc – 19 12 2023] – (CGWL)

Written by Customer Service on December 20, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LONDONMETRIC PROPERTY PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Form 8.3 – [Smart Metering Systems plc – 19 12 2023] – (CGWL)

Written by Customer Service on December 20, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree SMART METERING SYSTEMS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Form 8.3 – [LXi REIT PLC – 19 12 2023] – (CGWL)

Written by Customer Service on December 20, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LXi REIT PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [musicMagpie plc – 19 12 2023] – (CGAML)

Written by Customer Service on December 20, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree musicMagpie plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Pediatric Perfusion Products Market Size Worth 321.52 Million in 2032 | Emergen Research

Written by Customer Service on December 20, 2023. Posted in Mergers And Acquisitions.

Increasing prevalence of cardiac disorders such as congenital heart defects and heart failure in children is one of the major factors driving Pediatric Perfusion Products market revenue growth Vancouver, Dec. 20, 2023 (GLOBE NEWSWIRE) — The global pediatric perfusion products market size was USD 158.20 Million in 2022 and is expected to register a revenue CAGR of 7.4% during the forecast period, according to the latest analysis by Emergen Research. Increasing prevalence of cardiac disorders and heart failure, rising investments and funding toward production of such devices, and rapid advancements in cardiac monitor technology are some of the major factors driving the pediatric perfusion products market revenue growth. Pediatric perfusion refers to measures used to ensure that the child’s circulatory that is heart and blood...

Global Cardiac Monitors Market Size Worth USD 35.85 Billion in 2032 | Emergen Research

Written by Customer Service on December 20, 2023. Posted in Mergers And Acquisitions.

Increasing prevalence of cardiac disorders and heart failure is one of the major factors driving cardiac monitors market revenue growth Vancouver, Dec. 20, 2023 (GLOBE NEWSWIRE) — The global cardiac monitors market size was USD 23.9 Billion in 2022 and is expected to register a revenue CAGR of 4.1% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cardiac disorders and heart failure among people, rising investments and funding toward production of such devices, and rapid advancements in cardiac monitor technology are some of the major factors driving the market revenue growth. Portable cardiac monitors have grown increasingly important in building efficient cardiac care pathways as care becomes more coordinated between hospital and patient’s home. In contrast to previous...

Nxu Announces Third NxuOne™ EV Charging Solutions Location Within NEVI Corridor

Written by Customer Service on December 20, 2023. Posted in Public Companies.

Barstow, Calif. site location under contract within California’s NEVI Corridor 7 MESA, Ariz., Dec. 20, 2023 (GLOBE NEWSWIRE) — Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company creating innovative EV charging and energy storage solutions for the infrastructure we need to power our electrified future, is under contract to purchase a parcel of land in Barstow, Calif., a key location in California’s NEVI corridor 7. Barstow, situated where Interstate 15 and Interstate 40 intersect, is perfectly located in a major highway corridor, making it ideal for Nxu’s pursuit of electrifying high-demand highway routes with reliable and consistent charging solutions. National Electric Vehicle Infrastructure (NEVI) corridor 7 is one of the six corridor groups included in round 1 of the California Energy Commission’s...

Oculis Announces First Patient First Visit in Phase 3 OPTIMIZE-2 Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery

Written by Customer Service on December 20, 2023. Posted in Public Companies.

Initiation of the second Phase 3 OPTIMIZE-2 trial with OCS-01 once daily eye drop, follows the recently reported positive OPTIMIZE-1 trial results OPTIMIZE-2 topline readout expected before end of 2024 to support NDA submission OCS-01 is also being evaluated as potentially the first topical eye drop treatment for Diabetic Macular Edema (DME) in the DIAMOND program and for the treatment of Cystoid Macular Edema (CME) in the LEOPARD trialZUG, Switzerland, and BOSTON, Dec. 20, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis” or “the Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced First Patient First Visit (FPFV) in OCS-01 Phase 3 OPTIMIZE-2 trial for the treatment of inflammation and pain following cataract surgery. Data from the Phase 3 OPTIMIZE-2...

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Day: December 20, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice